Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

REGN - REGENERON PHARMACEUTICALS, INC.


IEX Last Trade
1138.9
0   0%

Share volume: 0
Last Updated: Fri 20 Dec 2024 09:00:10 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): 0.46%

PREVIOUS CLOSE
CHG
CHG%

$1,138.90
-428.70
0.60%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Fiscal Quarter Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Report Date 2022-11-03 2023-02-06 2023-05-04 2023-08-03 2023-11-02 2024-02-05 2024-05-02 2024-08-01
Cash flow financing -725.000 M -247.600 M -322.500 M -614.200 M -407.300 M -446.100 M 47.100 M -478.100 M
Other financing cash flows 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Cash flow 628.900 M 1.720 B 1.368 B 1.022 B 1.114 B 1.090 B 1.513 B 354.000 M
Net income 1.316 B 1.197 B 817.800 M 968.400 M 1.008 B 1.160 B 722.000 M 1.432 B
Depreciation 92.600 M 100.100 M 99.500 M 103.100 M 105.400 M 113.000 M 114.100 M 120.700 M
Changes in inventories 2.412 B 2.402 B 2.425 B 2.508 B 2.562 B 2.581 B 2.715 B 2.874 B
Changes in receivables 5.548 B 5.329 B 5.119 B 5.121 B 5.585 B 5.667 B 5.222 B 5.717 B
Investing Cashflow 192.300 M -1.858 B -235.700 M -2.387 B -496.300 M -66.200 M -1.687 B -557.200 M
Net Borrowings -4.767 B -5.452 B -6.664 B -6.592 B -7.786 B -8.529 B -8.231 B -7.787 B
Investing Activity Other 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Dividends Paid 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures -142.500 M -152.200 M -178.200 M -113.000 M -176.000 M -251.400 M -133.900 M -180.500 M
Cash Change 7.022 B 7.742 B 8.960 B 8.928 B 9.914 B 10.845 B 10.520 B 9.809 B